Your session is about to expire
← Back to Search
extended-release buprenorphine (XR-B) for Opioid Use Disorder
Study Summary
This trial will compare two forms of buprenorphine treatment for adults with opioid use disorder who are about to be released from a large city jail. Participants will be randomly assigned to receive either extended
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
Are there any available slots for patients to participate in this clinical trial?
"The ongoing trial, as documented on clinicaltrials.gov, is not seeking new participants at this moment. Originally shared on June 1st, 2024, with the most recent update made on March 5th, 2024. While recruitment for this specific study is paused currently, it's worth noting that there are presently active enrollment opportunities in 282 other research investigations."
What is the safety profile of extended-release buprenorphine (XR-B) in individuals?
"The safety rating for extended-release buprenorphine (XR-B) has been graded as a 3 by our team at Power, aligning with the Phase 3 trial status. This indicates existing evidence supporting both effectiveness and multiple reassurances regarding safety profile."
Share this study with friends
Copy Link
Messenger